Abstract:Abstract Background: Klebsiella oxytoca has become an important pathogen for opportunistic infections. Plasmid-mediated multidrug-resistant strains pose a significant risk to public health, especially when the strains produce carbapenemase. Here, we report the first detection of a blaKPC-2-IncFII plasmid and a blaVEB-3-IncC plasmid in a clinical multidrug-resistant K. oxytoca strain YL6, which has an entire cluster regularly spaced short palindromic repeat (CRISPR)-Cas immune system. Case presentation and methods: A 46-year-old man was hospitalized with chronic fibrous pneumonia. The K. oxytoca strain YL6 was isolated from his sputum sample. It was resistant to all tested antimicrobials, including almost all β-lactams, cephalosporins, quinolones, and aminoglycosides, except for colistin and tigecycline. To investigate this strain further, we conducted whole-genome sequencing and sequence alignment. Furthermore, the emerging plasmids were compared with similar ones available in the gene bank better to understand the genetic composition and evolution of the plasmids. Results: K. oxytoca strain YL6 belongs to ST27. This stain possesses a chromosome with 6,111,288 bp and two plasmids (An IncFII plasmid pYL6-1 and An IncC plasmid pYL6-2) with 101,530 bp and 145,051 bp, respectively. Genomic comparative analysis revealed that pYL-1 shared 70%~85% query cover and 98.65%-99.85% nucleotide identity with nineteen similar IncFII plasmids, and pYL-2 shared 79%~93% query cover and 99.74%-99.99% nucleotide identity with twenty-one similar IncC plasmids. Both groups of plasmids retained the complete coding region of the tra gene during their evolution. We also observed that the blaKPC-2 gene was located on an ISKpn19-orf1-orf2-Tn3-ISKpn27-blaKPC-2-ISKpn6-orf2-orf1-ISKpn19 structure in the multidrug resistance (MDR) region of pYL-1. Meanwhile, the blaVEB-3 gene in pYL6-2 was situated in an IS26-IS6100-blaVEB-3-transpone-ISAs1-qacEΔ1-sul1-ISCR1 casset. Based on additional data, the YL6 strain appears to possess an intact type I-E CRISPR -Cas immune system, which had been confirmed to inhibit the invasion and existence of the blaKPC-IncF plasmid effectively. The proto-spacers gene in pYL6-1, which are essential for the function of the CRISPR-Cas immune system, was no match to the CRISPR system sequence of K. oxytoca. Conclusions: We first reported a multidrug-resistant K. oxytoca with an intact CRISPR-Cas immune system harbors a blaVEB-3-IncC plasmid and a blaKPC-2-IncFII plasmid. There are no proto-spacer sequences matching the CRISPR system of K. oxytoca on the IncFII plasmid pYL6-1, which is crucial for identifying the foreign gene. It is inferred that the blaKPC-2-IncFII plasmid might escape the host's immune recognition by avoiding its proto-spacer DNA Base sequences complementing the gene arrangements of the strain's CRISPR system. The mutual adaptation between the invasive plasmid and host bacteria is bound to increase bacterial drug resistance further and lead to an antimicrobial public crisis, which calls for considerable attention.

Transmission barrier of the <i>bla</i><sub>KPC</sub> plasmid mediated by type I restriction-modification systems in <i>Escherichia coli</i>

Transmission Dynamics of Carbapenem-Resistant Klebsiella Pneumoniae Sequence Type 11 Strains Carrying Capsular Loci KL64 and Rmpa/rmpa2 Genes

The Type I-E CRISPR-Cas System Influences the Acquisition of Blakpc-Incf Plasmid in Klebsiella Pneumonia

High-risk KPC-producing Klebsiella pneumoniae lack type I R-M systems

Anti-Restriction Protein, KlcAHS, Promotes Dissemination of Carbapenem Resistance

CRISPR-Cas3 and Type I Restriction-Modification Team Up Against Blakpc-Incf Plasmid Transfer in Klebsiella Pneumoniae

Identification of Plasmid-Mediated Carbapenem-Hydrolyzing Β-Lactamase KPC-2 in Enterobacteriaceae

Coexistence of Bla KPC-IncFII Plasmids and Type I-E* CRISPR-Cas Systems in ST15 Klebsiella Pneumoniae.

Characterization of the bla VEB-3 bearing IncC plasmid and bla KPC-2 bearing IncFII plasmid in a type I-E CRISPR-Cas system harboring Klebsiella oxytoca stain

Coexistence of Blakpc-2–Incn and Mcr-1–Incx4 Plasmids in a ST48 Escherichia Coli Strain in China

A P7 Phage-Like Plasmid Carrying Mcr-1 in an ST15 Klebsiella Pneumoniae Clinical Isolate.

Replicative Transposition Contributes to the Evolution and Dissemination of KPC-2-producing Plasmid in Enterobacterales

Characterization of the genetic environment of <i>bla</i><sub>KPC</sub> in <i>Escherichia</i> <i>coli</i> isolates from hospitals in China

Detection of a Common Plasmid Carrying Blakpc-2 in Enterobacteriaceae Isolates from Distinct Cities in China.

Silent Transmission of an IS 1294b -Deactivated Mcr-1 Gene with Inducible Colistin Resistance

Prevalence of ST1049-KL5 Carbapenem-Resistant Klebsiella Pneumoniae with a Blakpc-2 and Blandm-1 Co-Carrying Hypertransmissible IncM1 Plasmid

Prevalence of ST1049-KL5 carbapenem-resistant Klebsiella pneumoniae with a bla KPC-2 and bla NDM-1 co-carrying hypertransmissible IncM1 plasmid

Regulation of Carbapenemase Gene Conjugation in Escherichia coli Clinical Isolates

Molecular Diversity and Plasmid Analysis of KPC-Producing Escherichia coli

CRISPR-Cas System in Antibiotic Resistance Plasmids in Klebsiella pneumoniae

Characterization of a Mcr-1 and CRISPR-Cas System Co-harboring Plasmid in a Carbapenemase-Producing High-Risk ST11 Klebsiella Pneumoniae Strain.